Renata enters into UK market
Friday, 14 November 2008
Renata Limited, a local pharmaceutical company, has entered into the UK market.
The first shipment of medicines of the company was sent to the UK on Tuesday, said a press release.
The Potent Product Facility (PPF) of the company received accreditation by the Medicines and Healthcare products Regulatory Agency (MHRA), UK last year.
The PPF located at Mirpur in the city manufactures hormones, steroids, oncology, and immunosuppressant products, the release added.
So far Renata, Square, and Eskayef have been approved by the MHRA, while Incepta and Beximco have been accredited by EMEA (Austria) and TGA (Australia) respectively.
Currently Bangladesh exports medicines to 72 countries. The export base although small is growing at nearly 50 per cent per annum.
The first shipment of medicines of the company was sent to the UK on Tuesday, said a press release.
The Potent Product Facility (PPF) of the company received accreditation by the Medicines and Healthcare products Regulatory Agency (MHRA), UK last year.
The PPF located at Mirpur in the city manufactures hormones, steroids, oncology, and immunosuppressant products, the release added.
So far Renata, Square, and Eskayef have been approved by the MHRA, while Incepta and Beximco have been accredited by EMEA (Austria) and TGA (Australia) respectively.
Currently Bangladesh exports medicines to 72 countries. The export base although small is growing at nearly 50 per cent per annum.